Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activityIoannis V. Kostopoulos,Despina Fotiou,Maria Gavriatopoulou,Pantelis Rousakis,Ioannis Ntanasis-Stathopoulos,Chrysanthi Panteli,Panagiotis Malandrakis,Magdalini Migkou,Nikolaos Angelis,Nikolaos Kanellias,Evangelos Eleutherakis-Papaiakovou,Foteini Theodorakakou,Maria Krevvata,Evangelos Terpos,Meletios-Athanasios Dimopoulos,Ourania Tsitsilonis,Efstathios KastritisBlood Cancer Journal(2024)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要